NEOGEN CORP
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation MI
Business Address 620 LESHER PLACE, LANSING, MI, 48912
Mailing Address 620 LESHER PLACE, LANSING, MI, 48912
Phone 5173729200
Fiscal Year End 0531
EIN 382367843
Financial Overview
FY2025
$4.55B
Total Assets
$170.61M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4/A Insider transaction amendment | January 29, 2026 | View on SEC |
| 3 Initial insider ownership report | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 8, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 2, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 13, 2025 | View on SEC |
Insider Trading
BUY 1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE
IDXX In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX In Vitro & In Vivo Diagnostic Substances
Intellia Therapeutics, Inc.
NTLA In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.